NASDAQ
RTIX

RTI Surgical Holdings, Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

RTI Surgical Holdings, Inc Stock Price

Vitals

Today's Low:
$3.1200
Today's High:
$3.3002
Open Price:
$3.2600
52W Low:
$1.46
52W High:
$5.4
Prev. Close:
$4.5500
Volume:
686036

Company Statistics

Market Cap.:
$0.234 billion
Book Value:
0.234
Revenue TTM:
$0.285 billion
Operating Margin TTM:
-9.16%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
-90.98%
Return on Assets TTM:
-3.42%
Return on Equity TTM:
-147.49%

Company Profile

RTI Surgical Holdings, Inc had its IPO on 2000-08-10 under the ticker symbol RTIX.

The company operates in the Healthcare sector and Medical Devices industry. RTI Surgical Holdings, Inc has a staff strength of 935 employees.

Stock update

Shares of RTI Surgical Holdings, Inc opened at $3.26 at the start of the last trading session i.e. 2020-07-22.

The stocks traded within a range of $3.12 - $3.3, and closed at $3.14.

This is a -30.99% slip from the previous day's closing price.

A total volume of 686,036 shares were traded at the close of the day’s session.

In the last one week, shares of RTI Surgical Holdings, Inc have slipped by -37.2%.

RTI Surgical Holdings, Inc's Key Ratios

RTI Surgical Holdings, Inc has a market cap of $0.234 billion, indicating a price to book ratio of 12.5449 and a price to sales ratio of 0.4939.

In the last 12-months RTI Surgical Holdings, Inc’s revenue was $0.285 billion with a gross profit of $0.000 billion and an EBITDA of $0.014 billion. The EBITDA ratio measures RTI Surgical Holdings, Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, RTI Surgical Holdings, Inc’s operating margin was -9.16% while its return on assets stood at -3.42% with a return of equity of -147.49%.

In Q2, RTI Surgical Holdings, Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 34.1%.

RTI Surgical Holdings, Inc’s PE and PEG Ratio

Forward PE
526.3158
Trailing PE
0
PEG
5.39

Its diluted EPS in the last 12-months stands at $-3.426 per share while it has a forward price to earnings multiple of 526.3158 and a PEG multiple of 5.39. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into RTI Surgical Holdings, Inc’s profitability.

RTI Surgical Holdings, Inc stock is trading at a EV to sales ratio of 1.161 and a EV to EBITDA ratio of 56.8591. Its price to sales ratio in the trailing 12-months stood at 0.4939.

RTI Surgical Holdings, Inc stock pays annual dividends of $None per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

RTI Surgical Holdings, Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

RTI Surgical Holdings, Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

RTI Surgical Holdings, Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, RTI Surgical Holdings, Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, RTI Surgical Holdings, Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$3.14
52-Week High
$5.4
52-Week Low
$1.46
Analyst Target Price
$5.5

RTI Surgical Holdings, Inc stock is currently trading at $3.14 per share. It touched a 52-week high of $5.4 and a 52-week low of $5.4. Analysts tracking the stock have a 12-month average target price of $5.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 2.53 indicating a short percent outstanding of 2%.

Around 1117% of the company’s stock are held by insiders while 7957.5% are held by institutions.

Frequently Asked Questions About RTI Surgical Holdings, Inc

The stock symbol (also called stock or share ticker) of RTI Surgical Holdings, Inc is RTIX

The IPO of RTI Surgical Holdings, Inc took place on 2000-08-10

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$0.42
0
+0.33%
$29.98
0
0%
Soliton, Inc (SOLY)
$22.58
0
0%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company’s implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.

Address

520 Lake Cook Road, Deerfield, IL, United States, 60015